Goldman Sachs’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,404
| Closed | -$46.8K | – | 5274 |
|
|
2025
Q1 | $46.8K | Sell |
7,404
-3,706
| -33% | -$23.4K | ﹤0.01% | 4923 |
|
|
2024
Q4 | $115K | Buy |
11,110
+163
| +1% | +$1.68K | ﹤0.01% | 4755 |
|
|
2024
Q3 | $141K | Buy |
10,947
+10,459
| +2,143% | +$134K | ﹤0.01% | 4563 |
|
|
2024
Q2 | $6.75K | Sell |
488
-6,205
| -93% | -$85.8K | ﹤0.01% | 4653 |
|
|
2024
Q1 | $2.08M | Buy |
6,693
+6,432
| +2,464% | +$2M | ﹤0.01% | 3181 |
|
|
2023
Q4 | $68.5K | Buy |
+261
| New | +$68.5K | ﹤0.01% | 4514 |
|
|
2021
Q3 | – | Sell |
-215
| Closed | -$86K | – | 5458 |
|
|
2021
Q2 | $86K | Sell |
215
-4
| -2% | -$1.6K | ﹤0.01% | 5149 |
|
|
2021
Q1 | $127K | Buy |
219
+2
| +0.9% | +$1.16K | ﹤0.01% | 4967 |
|
|
2020
Q4 | $123K | Buy |
+217
| New | +$123K | ﹤0.01% | 4435 |
|
|
2020
Q3 | – | Sell |
-512
| Closed | -$290K | – | 4510 |
|
|
2020
Q2 | $290K | Buy |
+512
| New | +$290K | ﹤0.01% | 3842 |
|